Yinfeng Qian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yinfeng Qian has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Andong He
Department of Medical Imaging, Anqing Medical Center of Anhui Medical University, Anqing, China
1 shared publicationChang-Bing Huang
Key Laboratory of Behavioral Science, Institute of Psychology, Chinese Academy of Sciences, Beijing, 100101, China
1 shared publicationDawei Yin
1 shared publicationFei Wang
Department of Medical Imaging, Anqing Medical Center of Anhui Medical University, Anqing, China
1 shared publicationGang Dai
1 shared publicationHao Chen
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (3) , 250
Grading of glioma and prediction of IDH mutation status via longitudinal relaxation time in rotating frame mapping on 5-T magnetic resonance imaging: added value to amide proton transfer-weighted imaging
Background: Accurate preoperative glioma grading and isocitrate dehydrogenase (IDH) mutation status prediction via conventional magnetic resonance imaging (MRI) remain challenging. We aimed to evaluate the performance of longitudinal relaxation time in rotating frame (T1rho) mapping and amide proton transfer (APT)-weighted chemical exchange saturation transfer (CEST) for grading gliomas and predicting IDH mutation status using 5-T MRI. Methods: Fifty patients with histopathologically confirmed glioma underwent 5-T MRI, including T2-weighted, T1-weighted, T1rho mapping, APT-weighted, and contrast-enhanced T1-weighted imaging. The T1rho and APT parameters were measured at the solid tumor portion, peritumoral edema, and contralateral normal-appearing white matter. In addition to absolute lesion values, the relative values (rT1rho and rAPT) were defined as the difference between the lesion and white matter. Differences between low-grade glioma (LGG) and high-grade glioma (HGG) and between IDH mutant-type and IDH wild-type were evaluated via the Mann-Whitney U test. Receiver operating characteristic (ROC) analyses were performed to assess the performance of each parameter and T1rho-plus-APT combination. Results: Among the 50 patients, 12 had LGG, 38 had HGG, 19 had the IDH mutant type, and 31 had IDH wild type. Compared with LGGs, HGGs exhibited significantly greater T1rho, rT1rho, APT, and rAPT values in both tumor and edema areas (P≤0.036). ROC analysis of individual parameters revealed that T1rho in edema achieved the highest area under the curve (AUC) in differentiating HGG from LGG (AUC, 0.974; sensitivity, 97.4%; specificity, 91.7%). With the combination of T1rho in edema and rAPT in tumor, the AUC further improved to 0.978 (sensitivity, 92.1%; specificity, 100%). Compared with the IDH mutant-type group, the IDH wild-type group had significantly greater T1rho and rT1rho values in tumor, T1rho and rT1rho values in edema, and APT and rAPT values in tumor (P≤0.003). T1rho in the edema achieved the highest AUC (0.883) in differentiating IDH wild type from IDH mutant type (sensitivity, 90.3%; specificity, 89.5%). Significant differences were noted between grade 2, 3, and 4 gliomas (P≤0.007). Conclusions: Both T1rho mapping and APT-CEST can be used to grade gliomas and differentiate IDH mutational status. Combining these two techniques further aids in the differentiation of HGG from LGG.
- 1 March 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (3) , 250
Open AccessGrading of glioma and prediction of IDH mutation status via longitudinal relaxation time in rotating frame mapping on 5-T magnetic resonance imaging: added value to amide proton transfer-weighted imaging
Background: Accurate preoperative glioma grading and isocitrate dehydrogenase (IDH) mutation status prediction via conventional magnetic resonance imaging (MRI) remain challenging. We aimed to evaluate the performance of longitudinal relaxation time in rotating frame (T1rho) mapping and amide proton transfer (APT)-weighted chemical exchange saturation transfer (CEST) for grading gliomas and predicting IDH mutation status using 5-T MRI. Methods: Fifty patients with histopathologically confirmed glioma underwent 5-T MRI, including T2-weighted, T1-weighted, T1rho mapping, APT-weighted, and contrast-enhanced T1-weighted imaging. The T1rho and APT parameters were measured at the solid tumor portion, peritumoral edema, and contralateral normal-appearing white matter. In addition to absolute lesion values, the relative values (rT1rho and rAPT) were defined as the difference between the lesion and white matter. Differences between low-grade glioma (LGG) and high-grade glioma (HGG) and between IDH mutant-type and IDH wild-type were evaluated via the Mann-Whitney U test. Receiver operating characteristic (ROC) analyses were performed to assess the performance of each parameter and T1rho-plus-APT combination. Results: Among the 50 patients, 12 had LGG, 38 had HGG, 19 had the IDH mutant type, and 31 had IDH wild type. Compared with LGGs, HGGs exhibited significantly greater T1rho, rT1rho, APT, and rAPT values in both tumor and edema areas (P≤0.036). ROC analysis of individual parameters revealed that T1rho in edema achieved the highest area under the curve (AUC) in differentiating HGG from LGG (AUC, 0.974; sensitivity, 97.4%; specificity, 91.7%). With the combination of T1rho in edema and rAPT in tumor, the AUC further improved to 0.978 (sensitivity, 92.1%; specificity, 100%). Compared with the IDH mutant-type group, the IDH wild-type group had significantly greater T1rho and rT1rho values in tumor, T1rho and rT1rho values in edema, and APT and rAPT values in tumor (P≤0.003). T1rho in the edema achieved the highest AUC (0.883) in differentiating IDH wild type from IDH mutant type (sensitivity, 90.3%; specificity, 89.5%). Significant differences were noted between grade 2, 3, and 4 gliomas (P≤0.007). Conclusions: Both T1rho mapping and APT-CEST can be used to grade gliomas and differentiate IDH mutational status. Combining these two techniques further aids in the differentiation of HGG from LGG.
- Open Access
- 13 May 2025
- Published by Springer Nature in European Radiology Experimental
- Vol. 9 (1) , 1-14
Comparison of four MRI diffusion models to differentiate benign from metastatic retropharyngeal lymph nodes
Background: Conventional magnetic resonance diffusion-weighted imaging (DWI) and morphological features have limitations in distinguishing benign from metastatic retropharyngeal lymph nodes (RLNs). We aimed to compare the value of continuous-time random walk (CTRW), fractional-order calculus (FROC), stretched-exponential model (SEM), and conventional DWI, in combination with morphological features, for differentiating between the two groups. Methods: Fifty-nine patients with 68 RLNs (23 benign and 45 metastatic) were enrolled. All patients underwent DWI with 12 b-values. Diffusion data were reconstructed using conventional DWI, SEM, FROC, and CTRW models, yielding nine parameters: apparent diffusion coefficient (ADC), distributed diffusion coefficient (DDC)SEM, αSEM, DFROC, βFROC, μFROC, DCTRW, αCTRW, and βCTRW. Diffusion parameters and morphological features were compared using Mann–Whitney U, independent sample t, or χ2 tests. Logistic regression analysis was performed to identify the best diffusion indicator for classification and to develop a multiparameter model combining morphological features. Area under the receiver operating curve (AUC) and DeLong tests were used. Results: Significant differences in diffusion parameters were found between benign and metastatic RLNs, except for αCTRW (p ≤ 0.022). Benign RLNs exhibited higher ADC, DDCSEM, DFROC, and DCTRW, while metastatic RLNs had higher αSEM, βFROC, μFROC, and βCTRW. Multivariate logistic regression analysis identified βCTRW as the optimal single diffusion indicator (AUC = 0.913). The combined model of βCTRW with morphological features further improved diagnostic performance and yielded an AUC of 0.948. Conclusion: βCTRW is an effective noninvasive biomarker for distinguishing between benign and metastatic RLNs. Thus, combining βCTRW with morphological features enhances diagnostic efficiency. Relevance statement: This study demonstrates that βCTRW, derived from the continuous-time random walk diffusion model, when integrated with morphological features, offers a reliable, noninvasive diagnostic approach for differentiating between benign and metastatic retropharyngeal lymph nodes. Key Points: Non-Gaussian diffusion metrics outperformed conventional DWI. βCTRW was the best indicator for distinguishing benign from metastatic lymph nodes. Combining βCTRW with minimal axial diameter further improved diagnostic efficiency. Graphical
- 13 May 2025
- Published by Springer Nature in European Radiology Experimental
- Vol. 9 (1) , 1-14
Open AccessComparison of four MRI diffusion models to differentiate benign from metastatic retropharyngeal lymph nodes
Background: Conventional magnetic resonance diffusion-weighted imaging (DWI) and morphological features have limitations in distinguishing benign from metastatic retropharyngeal lymph nodes (RLNs). We aimed to compare the value of continuous-time random walk (CTRW), fractional-order calculus (FROC), stretched-exponential model (SEM), and conventional DWI, in combination with morphological features, for differentiating between the two groups. Methods: Fifty-nine patients with 68 RLNs (23 benign and 45 metastatic) were enrolled. All patients underwent DWI with 12 b-values. Diffusion data were reconstructed using conventional DWI, SEM, FROC, and CTRW models, yielding nine parameters: apparent diffusion coefficient (ADC), distributed diffusion coefficient (DDC)SEM, αSEM, DFROC, βFROC, μFROC, DCTRW, αCTRW, and βCTRW. Diffusion parameters and morphological features were compared using Mann–Whitney U, independent sample t, or χ2 tests. Logistic regression analysis was performed to identify the best diffusion indicator for classification and to develop a multiparameter model combining morphological features. Area under the receiver operating curve (AUC) and DeLong tests were used. Results: Significant differences in diffusion parameters were found between benign and metastatic RLNs, except for αCTRW (p ≤ 0.022). Benign RLNs exhibited higher ADC, DDCSEM, DFROC, and DCTRW, while metastatic RLNs had higher αSEM, βFROC, μFROC, and βCTRW. Multivariate logistic regression analysis identified βCTRW as the optimal single diffusion indicator (AUC = 0.913). The combined model of βCTRW with morphological features further improved diagnostic performance and yielded an AUC of 0.948. Conclusion: βCTRW is an effective noninvasive biomarker for distinguishing between benign and metastatic RLNs. Thus, combining βCTRW with morphological features enhances diagnostic efficiency. Relevance statement: This study demonstrates that βCTRW, derived from the continuous-time random walk diffusion model, when integrated with morphological features, offers a reliable, noninvasive diagnostic approach for differentiating between benign and metastatic retropharyngeal lymph nodes. Key Points: Non-Gaussian diffusion metrics outperformed conventional DWI. βCTRW was the best indicator for distinguishing benign from metastatic lymph nodes. Combining βCTRW with minimal axial diameter further improved diagnostic efficiency. Graphical
- Open Access
- 24 January 2017
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 32 (3) , 685-692
Frequency-dependent changes in the amplitude of low-frequency fluctuations in patients with Wilson’s disease: a resting-state fMRI study
To investigate the frequency-dependent changes in the amplitude of low-frequency fluctuations (ALFF) in patients with Wilson’s disease (WD). Resting-state function magnetic resonance imaging (R-fMRI) were employed to measure the amplitude of ALFF in 28 patients with WD and 27 matched normal controls. Slow-5 (0.01–0.027 Hz) and slow-4 (0.027–0.073 Hz) frequency bands were analyzed. Apart from the observation of atrophy in the cerebellum, basal ganglia, occipital gyrus, frontal gyrus, precentral gyrus, and paracentral lobule, we also found widespread differences in ALFF of the two bands in the medial frontal gyrus, inferior temporal gyrus, insula, basal ganglia, hippocampus/parahippocampal gyrus, and thalamus bilaterally. Compared to normal controls, WD patients had increased ALFF in the posterior lobe of the cerebellum, inferior temporal gyrus, brain stem, basal ganglia, and decreased ALFF in the anterior lobe of the cerebellum and medial frontal gyrus. Specifically, we observed that the ALFF abnormalities in the cerebellum and middle frontal gyrus were greater in the slow-5 than in the slow-4 band. Correlation analysis showed consistently positive correlations between urinary copper excretion (Cu), serum ceruloplasmin (CP) and ALFFs in the cerebellum. Our study suggests the accumulation of copper profoundly impaired intrinsic brain activity and the impairments seem to be frequency-dependent. These results provide further insights into the understanding of the pathophysiology of WD.
- 24 January 2017
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 32 (3) , 685-692
Open AccessFrequency-dependent changes in the amplitude of low-frequency fluctuations in patients with Wilson’s disease: a resting-state fMRI study
To investigate the frequency-dependent changes in the amplitude of low-frequency fluctuations (ALFF) in patients with Wilson’s disease (WD). Resting-state function magnetic resonance imaging (R-fMRI) were employed to measure the amplitude of ALFF in 28 patients with WD and 27 matched normal controls. Slow-5 (0.01–0.027 Hz) and slow-4 (0.027–0.073 Hz) frequency bands were analyzed. Apart from the observation of atrophy in the cerebellum, basal ganglia, occipital gyrus, frontal gyrus, precentral gyrus, and paracentral lobule, we also found widespread differences in ALFF of the two bands in the medial frontal gyrus, inferior temporal gyrus, insula, basal ganglia, hippocampus/parahippocampal gyrus, and thalamus bilaterally. Compared to normal controls, WD patients had increased ALFF in the posterior lobe of the cerebellum, inferior temporal gyrus, brain stem, basal ganglia, and decreased ALFF in the anterior lobe of the cerebellum and medial frontal gyrus. Specifically, we observed that the ALFF abnormalities in the cerebellum and middle frontal gyrus were greater in the slow-5 than in the slow-4 band. Correlation analysis showed consistently positive correlations between urinary copper excretion (Cu), serum ceruloplasmin (CP) and ALFFs in the cerebellum. Our study suggests the accumulation of copper profoundly impaired intrinsic brain activity and the impairments seem to be frequency-dependent. These results provide further insights into the understanding of the pathophysiology of WD.